Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.

Christine CW, Langston JW, Turner RS, Starr PA.

J Neurosurg. 2009 Feb;110(2):234-8. doi: 10.3171/2008.8.JNS08882.

PMID:
19099380
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The translational value of the MPTP non-human primate model of Parkinsonism for deep brain stimulation research.

Tass PA, Qin L, Hauptmann C, Dovero S, Bezard E, Boraud T, Meissner WG.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:663-6. doi: 10.1109/IEMBS.2011.6090148.

PMID:
22254396
[PubMed - indexed for MEDLINE]
3.

Neuroprotection in Parkinson models varies with toxin administration protocol.

Anderson DW, Bradbury KA, Schneider JS.

Eur J Neurosci. 2006 Dec;24(11):3174-82.

PMID:
17156378
[PubMed - indexed for MEDLINE]
4.

Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.

Oiwa Y, Eberling JL, Nagy D, Pivirotto P, Emborg ME, Bankiewicz KS.

Front Biosci. 2003 Sep 1;8:a155-66.

PMID:
12957824
[PubMed - indexed for MEDLINE]
5.

Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.

Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ.

Mov Disord. 2000 May;15(3):459-66.

PMID:
10830409
[PubMed - indexed for MEDLINE]
6.

[Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].

Luquin MR, Obeso JA, Herrero MT, Laguna J, Martínez-Lage JM.

Neurologia. 1991 Oct;6(8):287-94. Review. Spanish.

PMID:
1790005
[PubMed - indexed for MEDLINE]
7.

Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.

Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.

J Neural Transm. 2001;108(8-9):985-1009.

PMID:
11716151
[PubMed - indexed for MEDLINE]
8.

Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.

Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T.

Synapse. 2001 Jun 1;40(3):225-34.

PMID:
11304760
[PubMed - indexed for MEDLINE]
9.

Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys.

Wallace BA, Ashkan K, Heise CE, Foote KD, Torres N, Mitrofanis J, Benabid AL.

Brain. 2007 Aug;130(Pt 8):2129-45. Epub 2007 Jun 20.

PMID:
17584773
[PubMed - indexed for MEDLINE]
Free Article
10.

Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.

Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ.

Life Sci. 1985 Jan 21;36(3):213-8.

PMID:
3871241
[PubMed - indexed for MEDLINE]
11.

Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.

Liu J, Wang YY, Liu L, Wang QD, Yuan ZY, Zhang ZX, Gu P, Wang MW.

Neurosci Lett. 2008 Dec 26;448(2):184-8. doi: 10.1016/j.neulet.2008.10.070. Epub 2008 Oct 25.

PMID:
18977411
[PubMed - indexed for MEDLINE]
12.

Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.

During MJ, Kaplitt MG, Stern MB, Eidelberg D.

Hum Gene Ther. 2001 Aug 10;12(12):1589-91.

PMID:
11529246
[PubMed - indexed for MEDLINE]
13.

JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.

Wang Y, Zhang Y, Wei Z, Li H, Zhou H, Zhang Z, Zhang Z.

J Neurol Sci. 2009 Oct 15;285(1-2):172-7. doi: 10.1016/j.jns.2009.06.034. Epub 2009 Jul 14.

PMID:
19604516
[PubMed - indexed for MEDLINE]
14.

The role of the pedunculopontine tegmental nucleus in experimental parkinsonism in primates.

Matsumura M, Kojima J.

Stereotact Funct Neurosurg. 2001;77(1-4):108-15.

PMID:
12378066
[PubMed - indexed for MEDLINE]
15.

Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.

Shaw VE, Keay KA, Ashkan K, Benabid AL, Mitrofanis J.

Parkinsonism Relat Disord. 2010 Jun;16(5):338-44. doi: 10.1016/j.parkreldis.2010.02.008. Epub 2010 Mar 12.

PMID:
20227323
[PubMed - indexed for MEDLINE]
16.

Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism.

Faherty CJ, Raviie Shepherd K, Herasimtschuk A, Smeyne RJ.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):170-9.

PMID:
15790541
[PubMed - indexed for MEDLINE]
17.

Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.

Ohashi S, Mori A, Kurihara N, Mitsumoto Y, Nakai M.

Neurosci Lett. 2006 Jun 19;401(1-2):183-7. Epub 2006 Apr 3.

PMID:
16581184
[PubMed - indexed for MEDLINE]
18.

Experimental parkinsonism in primates.

Matsumura M.

Stereotact Funct Neurosurg. 2001;77(1-4):91-7. Review.

PMID:
12378063
[PubMed - indexed for MEDLINE]
19.

A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.

Yano R, Yokoyama H, Kuroiwa H, Kato H, Araki T.

J Mol Neurosci. 2009 Sep;39(1-2):211-9. doi: 10.1007/s12031-009-9181-z. Epub 2009 Feb 7. Erratum in: J Mol Neurosci. 2009 Sep;39(1-2):320.

PMID:
19199078
[PubMed - indexed for MEDLINE]
20.

Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease.

McCollum M, Ma Z, Cohen E, Leon R, Tao R, Wu JY, Maharaj D, Wei J.

Mol Neurobiol. 2010 Jun;41(2-3):410-9. doi: 10.1007/s12035-010-8118-4. Epub 2010 Apr 21.

PMID:
20405343
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk